The impact of blood glucose monitoring on depression and distress in insulin-nave patients with type 2 diabetes

Current Medical Research and Opinion

Volumn 27, Issue SUPPL. 3, 2011, Pages 39-46

  Fisher, L ^a   Polonsky, W ^b   Parkin, C G ^c   Jelsovsky, Z ^d   Amstutz, L ^e   Wagner, R S ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CGParkin Communications Inc   (United States)

^d BioStat International Inc   (United States)

^e Roche Diagnostics Corporation   (United States)

Author keywords

Depressive symptoms; Diabetes; Diabetes distress; Glucose monitoring; SMBG

Indexed keywords

ANTIDIABETIC AGENT; INCRETIN MIMETIC AGENT; ORAL ANTIDIABETIC AGENT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; EXPERIMENTAL STUDY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; LIFESTYLE MODIFICATION; MEDICAL PRACTICE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; SELF MONITORING; SELF MONITORING BLOOD GLUCOSE; SIDE EFFECT;

AGED; BLOOD GLUCOSE SELF-MONITORING; DEPRESSION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED;

EID: 81855168269     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.619176     Document Type: Article

References (21)

1. Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ 2007;335:132
2. Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003;29:587-94 (Pubitemid 38082160)
3. O'Kane MJ, Bunting B, Copeland M, et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008;336:1174-7 (Pubitemid 351809278)
4. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002;25:1928-32 (Pubitemid 41071046)
5. Siebolds M, Gaedeke O, Schwedes U. Self-monitoring of blood glucose-psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication. Patient Educ Couns 2006;62:104-10 (Pubitemid 43832065)
6. Franciosi M, Pellegrini F, De Berardis G, et al. The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies. Diabetes Care 2001;24:1870-7 (Pubitemid 33716493)
7. French DP, Wade AN, Yudkin P, et al. Self-monitoring of blood glucose changed non-insulin-treated type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial. Diabet Med 2008;25:1218-28
8. Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. BMJ 2007;335:493
9. Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1c levels in poorly controlled, noninsulintreated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262-7
10. Bech P, Olsen LR, Kjoller M, et al. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003;12:85-91 (Pubitemid 36850039)
11. Fisher L, Mullan JT, Arean P, et al. Diabetes distress but not clinical depression or depressive symptoms is associated with glycaemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010;33:23-8
12. Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycaemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-42 (Pubitemid 30480020)
13. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6
14. Polonsky W, Fisher L, Schikman C, et al. The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]. BMC Fam Pract 2010;11:37
15. Kroenke K, Spitzer RL. A new depression and diagnostic severity measure. Psychiatric Annals 2002;32:509-21
16. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care 2005;28:626-31 (Pubitemid 40315323)
17. Institute SAS. SAS/STAT User's Guide, 8th edn. Cary, NC, USA: SAS Institute, Inc., 1999
18. Fitzmaurice G, Laird NM, Ware JH. Applied Longitudinal Analysis. Hoboken, NJ, USA: John W. Wiley and Sons, 2004
19. Little RJA, Rubin DB. Statistical Analysis with Missing Data, 2nd edn. Hoboken, NJ, USA: John W. Wiley and Sons, 2002
20. Fisher L, Mullan JT, Skaff MM, et al. Predicting diabetes distress in patients with type 2 diabetes: a longitudinal study. Diabet Med 2009;26:622-7
21. Fisher L, Skaff MM, Mullan JT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med 2008;25:1096-101